That's significant because the GI tract is the most common site of bleeding with DOACs, and this type of bleeding is the only ...

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

A Fitbit got a reporter to see his doctor — and ultimately go under the knife. Are wearables the next wave in heart health?

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

The study, recently published in the Journal of the American Heart Association, adds to a body of research dispelling the ...

Our Lady of Lourdes Regional Medical Center is embracing cutting-edge technology to transform how heart conditions are ...

Saint Francis treated its first patient with pulsed-field ablation, which delivers pulsed electric fields to tissue to treat ...

The results will support the company’s application for expanded labeling of its popular Farapulse pulsed field ablation ...

The Circular Ring 2 features an AFib detection system that should greatly help the device find its space in the smart ring ...

Atrial fibrillation (AFib) is a heart condition that can affect even the fittest individuals, often presenting without obvious symptoms. As a dedicated cyclist in good health, I was surprised by my ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...